Dermal fibrosis, characterized by collagen accumulation, is the hallmark of several cutaneous diseases. To examine the mechanisms of collagen deposition in fibrotic skin diseases, fibroblast cultures were es tablished from the skin of pa tients with progressive systemic sclerosis, morphea, scleredem a, famili al cutaneous collagenoma, connective tissu e nevi of the collagen type, or keloids; these patients serv e d as prototypes of fibrotic skin diseases with varying clinical features and potentially different etiologic factors. Collagen production was assayed by the synthesis of
Dermal fibrosis, characterized by collagen accumulation, is the hallmark of several cutaneous diseases. To examine the mechanisms of collagen deposition in fibrotic skin diseases, fibroblast cultures were es tablished from the skin of pa tients with progressive systemic sclerosis, morphea, scleredem a, famili al cutaneous collagenoma, connective tissu e nevi of the collagen type, or keloids; these patients serv e d as prototypes of fibrotic skin diseases with varying clinical features and potentially different etiologic factors. Collagen production was assayed by the synthesis of
[3H] hydroxy proline, and types I and III procollagen messenger RNA (mRNA) levels were determined by dot blot hybridiza tions using human type I and type III procollagenspecific cDNA probes. The collagen production in fibroblast cultures from the fibrotic diseases was increased up to 6 -fold over the controls, and a relatively good co rrelation D ernul fibrosis is the hallm ark of several diseases affectin g skin [2] [3] [4] . The cutaneous diseases with dermal fibrosis can be cl assified into several distinct categori es on the bas is of clinical features, associated findin gs, and inheritance (Table I) . For exa mple, rhe c u t aneous fibrosis ca n be part of a generali zed connective tissue involve ment, as in progress ive systemic sclerosis, or it ca n be strictI y localized in the skin , as in mo rphea. The dermal fibrosis can result fro m an immuno logic o r metabolic aberrati on, o r it Manuscript received Jul y 24, 1986 ; accepted fo r publication September 12, 1986. T his study was suppo rted in part by the United States Public Hea lth Se rvice, N ati onal In stitutes of Health grants AM 12129, AM 19537, GM 28833 , AM 28450, and AM 35297.
* A preliminary report of the stud y was presented at the Annu al ca n be chem icall y induced. Most fibroti c conditions are acq uired, but dermal fibrosis is the major clinical feature in two heritable diseases, namely familial cutaneous collageno m a [5] and the SI13-green patches in tuberous sclerosis [6] (Table I) . The cutaneous diseases with dermal fibrosis share several histo pathologic features [7] . The dermis is usuall y thickened with th e extracellular matrix of th e connecti ve tiss ue in va din g areas of the subcutaneous adipose tissue. The ex tracellular matrix is predominantly composed of collagen, which for exa mple in the case ofkeloids comprises approximately 60% of the dry weight of the tissue [8] . Thus, there is a net in crease in the amount of coll agen in the lesional skin in fibrotic diseases. Furthermore, particularly in the ea rl y sta ges of the fibrotic process, there is a marked fibroblas tic cell infiltrate.
The excessive accumulation of collagen in the fibrotic skin les ions ca n res ult from abe rrati ons in collagen metabolism by several different mechanism s, as for example , by increased collagen prod ucti on by fibroblasts, reduced degradation of collagen either intra-or extracellularl y, o r expansion of fibroblast subpopulations active in collagen production. Previous studies utili zing cell culture techniques have es tablished that in so me fibroti c diseases the skin fibroblasts are overproducing collagen. This has been shown to be true in cases of progressive systemic sclerosis [9] [10] [11] [12] , morphea [13] , and keloids [8, 14, 15] . Also, in the case of scleroderma, recent studies have sugges ted that the levels of type I procollagen messenge r RNA (mRNA) are similarly increased [16, 17] . To explore the mechanisms leading to dermal fibrosis, we have exa mined fibr oblas ts derived fro m 6 pati ents, each with indica ted in Tab le II. The primary cultures w e re es ta blished from biops y specimens obtained from th e lesion al s kin. Contro l cultures were established from age-matched n o rmal subj ects w h o unde rw ent a s urg ical procedure for cos m etic reaso ns. The co ntro l cultures were esta blished from the si te-m atc hed area of skin . The primary cultures w e re passed by trypsini za tion , and the second a r y cultures were m aintained in Dulbecco's m o difi ed Eagle's m edium (DMEM) und e r stand ard tissue culture co nditions [20] . For collagen an alyses, th e fibroblast cultures in earl y visual conflu ency we re incubated in DMEM supple m ented with 20% fe tal ca lf se rum and 25 ,ug/ ml of ascorbic acid. Afte r a 4-h pre incubation, [JH] pro line (L-[2,3,4,5-J H]proline, 109 C i/ mmol ; Ame rsha m) was added and the in cuba ti o ns were continued for 18 h . At the end of in cubati o n , th e m edium was re moved a nd mi xed with protease inhibitors to g ive final co ncentrations o f 10 mM N a2EDTA, 10 mM N-eth y lm aleimide, and 1 mM ph en y lm e thylsulfonyl flu o rid e. The cell la yer was rinsed w ith 0.15 M NaC l, 50 mM Tris-H C l, pH 7 .5, and the rinse was co mbined with the medium fra c tion . The cell s were scraped w ith a rubbe r police m an into 50 mM Tris-HC l, pH 7.5, containin g 1. 0 M N aC I and th e protease inhibitors indicated .above . The cell s w ere h om ogenized with a Teflon-g lass h o m ogeni ze r at 4°C. Aliquo ts of th e cell s and m edium were dialy ze d aga inst dis till ed water, h ydrolyzed a t 120°C for 16 h , and assayed for [3 H]hydrox yproline [21] . Aliquots of th e cell homo ge nates w ere also dia lyzed against 1 mM Tris-HCl , pH 7.5 , co ntaining 0.15 M N aC l, and assayed for cell protein [22] . a different type of fibrotic s kin disease, for their collagen m etabo li s m in vitro. These patients serve as prototypes representing diffe rent phen oty pic fo rms of cutaneous fibrosi s.
For assay of types I and 11/ procolJa gen mRN A levels, pol y(A) + -RN A was isolated from the cells by o li go-dT cellulose cllromatog ra phy, as indicated previously [8,23 ,24] . The recovery of th e poly(A) + -RN A was determin ed by a technique utilizing rabbit g lo bin mRN A as an inte rnal s tand ard 18] . The collagen-specific mRNA levels were then d ete rmin ed by dot blot hybridiza tions utili zing well-ch aracterized human proa l(I), proa2(I), and proal(lII) collagen-specific complementary DNA (cD NA) probes [25] [26] [27] . Hybridiza tion s were p erform ed by dottin g aliquots of poly(A) +-RNA in distilled w ate r mi xed with an equ al vo lume ofa so lu tion containing 3 vol of20 x SSC (0.15 M N aC l, 0.015 M sodium citrate, pH 6.8) and 2 vol of 37% formaldehyde [28] . The sa mples w e re hea ted at 65°C for 5 min and dotted o n nitrocellulose filte rs usin g a vacuum m anifold (Minifold II, Schleicher & Schuell). The nitrocellulose filte rs w e re air dried and hea ted at 78°C for 90 min in a vacuum ove n . The filt ers were th en prehybridized at 42°C in a so lution co ntaining 3 X SSC, 50% formamide, 0.1 % sodium dodecyl sulfate (SDS) , 50 ,ug/ ml denatured salm on sperm DNA, 0.02% po lyviny l p yrrolido ne, 0.02% b ovine serum albumin , and 0.02% Ficoll [28] . The hybridiza tions w e re carried out in th e sa me solutio n co ntaining 10 n g/ ml of a collagen-specific cDNA , la beled by ni ck translation with a_ J2 p_ labeled deo xy ribonucl eo tid es to a specifi c activity of approx i-
PATIENTS AND METHODS
Fibro blas t cultures w ere established from the skin of 6 patients with derm al fibro sis. The clinical fe atures of th ese patie nts a re 
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SSC , all at 6 5°C , 10 min each . The stringency of th e h y bridiza ti ons and the w as hing conditio ns preclude an y cross-hybridiza tion between type I and type III procoUagenmRNAs wh e n t y pe-specifi c probes are used , as d etected b y N o rthern blo t ana ly ses [30] . The fi lters were dried and ex posed to x-ray film s (Dupo nt, C ronex) in cassettes e quipped with intensifying screens. The rnRNA-[ 32 P] cDNA h y brids w ere visua lized by auto radio gra phy a nd qu antitated by liquid scintillatio n countin g. The results we r e corrected fo r the specifi c ac tivity and leng th o f the cON A prob es, as well as fo r chain compositio n of type I and III procoll agens.
Sta ti sti cal eva luati o ns w ere perfo rmed b y Aspin-Welch twosampl e tes t o f m ea ns.
RES ULTS
Pr o du c ti o n of p roco ll age n , m eas ured as synth es is o f [3H]hydroxy p ro line in cultures in cubated with r3Hlpro line, was incr eased in all 6 cell li nes studie d (Tab le III). The hi g hes t in crease, approximately 6-fold , was no ted in fibr o blas t cultures es tablished fro m patient no. 2 with morph ea, while the values in o ther cell cultures we re in creased b y 1. 8-to 3.0-fo ld (T able III) .
To exa min e the m echanism s o f in creased proco ll agen pro du ctio n in these cultures, the levels o f ty pes I and ty pe III procoll agen m RNA s we re meas ured . The ty pe 1 procoll agen mRNA levels, de t e rmined b y h y bridiza ti o ns with pro a 2(1) coll agen cDNA , in the c ulture fr o m fib ro ti c skin diseases w ere 16.7 ± 3. 1 cpm / ng pol y (A) + -RNA (m can ± SE M) , and the corres po ndin g values in th e contro l fibr o blas t cultures w ere 6.0 ± 0.3 cpm/ n g . The ra ti o o f proal (1)/ proa2(1) mRN As in all cultu res w as approxim a t e l y 2: 1, a nd consequently , the aSS JY of ty pe I procoIl agcn m RN A levels utilizing either pro al (I) o r proa2(1) specifi c cD NA pro b e ga ve the sa m e results aft e r correc tio n fo r chain compos ition of t y p e I procollagen . A rel atively good overall correlatio n berwee n the coll agen pro du cti o n and the type I procoll agen mRNA level s was o bserved (Fig 1) .
Th e ratio of ty pe l!ty pe III procoll agen mRN As was also examine d b y h y bridiza ti o ns w ith proal (I) and p roa l (Ill) co ll agenspeci fic c DNA pro bes. This rati o in contro l fib ro blas t cultures was 5 .9 ± 1.6 (mean ± SO) . A m ark edl y increased type I !II I pro c ollagen mRNA ratio was meas ured in the kel o id cell lin e studi e d (patient no. 6), whe reas sli g htly redu ced va lues w e re no ted in cases of m o rphea (pati ent n o. 2) and famili al cutaneous collagen o m a (patient no . 4) (Fi g 2).
DIS C U SSION
In thi s stud y, w e have d emonstrated that fibr o blast cultures esta bli s h e d fro m a variet y o f fibro ti c skin diseases display enhanced coll agen pro du cti o n in v itro . This o bse r va ti o n suggests, there- "T he Ilum bers refe r to p"tients in Table II Figure 1 . Correl ation betwcen co ll age n produ ction and type I procollagen mRNA levels in fibr oblast cultures established from patients with cuta neous fibroses. Coll age n prod ucti on was assayed by deter min ati on of newly synth es ized 13H Jh yd roxy prolin e, ex pressed as dpm per JLg cell pro tein (sce Ta ble III). Ty pe I procoll agen mRNA levels were determined by hybridiza tions with proa2(1) coll agen-specific cDNA probe, and the va lues were expressed as cpm pe r ng poly( A) + -RNA (see Resl/lts). T he va lues in fib ro bl as t cultures from pati ents with cuta neous fi bros is (F) are exp ressed as percent (mean ± SEM) of the co rres pondin g co nt rols (C) which represent 6 paired norm al fi bro blast cultures exa min ed un de r identi ca l culture conditi ons. .2 Figure 2 . T he ra tio of ty pe 1/ 111 procoll agcn mRN As in fib roblast cultures es tablished from patients with cutaneous fi brosis or from site-matched skin of age-matched control subjects. T he cul tures we re in cubated in a parallel mann er un der identi cal ti ss ue culture conditions and exa mined at ea rl y vis ual conAu ency. Poly( A) + -RN A was iso la ted by oli go-dT cellul ose chromatog raph y and dotted on nitrocellulose fil ters in seri al dilutions. Parallel fi lters were hybridized with hum an proa l (1) and proa l (1Il) co ll agen cD N A probes. T he limits of mea n ± SD of 5 control cultu res arc indicated by the harched nren . T he num bers by the values obtai ned with fi bro ti c skin diseases (so lid circles) refe r to pati ents in Ta ble II . T he indi vidual va lu es arc th e mea ns of 2 se parate ex perim ents, each represe ntin g 6 parallel determin ations with a va ri ation of < 18% (SD).
fo re, that the deposition o f collagen, w hi ch ca n be dem o nstrated by histopathologic examin ati on of the affected skin , res ults from in creased synthesis of this protein in vivo. Th ese o bserva ti o ns are in ag reem ent w ith prev io us dem o nstrati ons that the collagen prod ucti on by fi bro blas t cul tures es tablished fro m patients w ith prog ressive systemic sclerosis [9-1 2J, m o rphea [1 3] . and keloids [8, 14, 15] is in creased .
Coll agen synthesis by human skin fibro blas ts is a process invo lving several distin ct intracellul ar steps [31 ,32] . First, the expressio n o f colla.gen gene is initiated by · tra nscription of th e in fo rm ati on in D NA to a co rrespo ndin g mRNA precursor m o lecul e w hi ch , in additio n to the codin g sequences (exons) , contains no ncodin g sequences (intro ns) [32] . The precursor mRNA undergoes several posttranscriptional m odifi ca ti ons, including rem o val of the introns by spli cin g. Fun cti onal mRNA m olecul es then serve as template for the synthesis of proco ll agen po lypeptides. These polypeptides, pro-a chain s, are extensively m odifi ed by co-and posttranslati onal reactio ns w hi ch are enzy m ati call y m edi ated [33] . U pon co mpleti o n of the intracellular events, the procollagen m olecules are secreted into the extracellul ar space where they undergo fu rther m o difica ti o ns, includin g the rem o val of th e precursorspecific extensio ns [31] . Thus, the produ cti on o f the extracellul ar coll age n m o lecul es could be controlled at several different levels of biosynthesis, either intracellularl y o r extracellul arl y .
In this stud y, we dem onstrated that the increased procollagen producti on by cultured fibro blasts w as acco mpanied by a parallel in crease in type I procollagen mRNA levels. This o bservation suggests then that procollagen produ ction in fibrobl as t cultures es tablished from fibroti c skin diseases reflects eleva ted levels of the corres ponding procoll agen mRNA . The in creased mRNA levels m ay res ult fro m enhanced transcriptional activity o f the corres ponding genes [34] . or alternatively , increased stability associated with lon ge r half-life o f the collagen mRN As could lead to accumulati on of these m olecules [35] . N evertheless, the demonstrati on of a correl ation between type I procollagen mRNA levels on one hand and the p rodu cti on o f the corres ponding protein on the o ther, furth er suppo rts previous suggesti ons [36, 37] that a m aj o r contro l point in collagen producti on exists on the pretranslationallevel. These data also indicate that the differen ces in the rate of coll agen producti on between the fibroblasts from the fib ro tic diseases and the contro ls ca nnot be explained by altered regulati on o n the posttranscriptional level [38] .
Recent studies have clea rly established that collagens are a family o f closely related ye t geneticall y distinct proteins [39, 40] . The two m aj o r types o f procollagens synthesized by human skin fibrobl as ts in culture are type I and type III [41, 42] . In this study , we exa mined the relative expression o f type I and type III procollagen genes by m easuring the corres ponding mRNA levels. In control fibrobl as ts, the rati o o f type IIIII procollagen mRNAs was 5.9, a value which ag rees with the ratio of type IIlII procollagens synthesized by these cells in culture [42] . The rati o of type IIIlI procoll agen mRN A w as m arkedly elevated in pati ent no. 6 with kel o ids, sugges tin g that keloid fibrobl as ts m ay offer a unique model b y which to stud y the independent regul ation of gene expression o f two geneti ca ll y distin ct procoll agens [30] . In contras t to keloids, slightl y reduced type IIIII procoll agen mRNA rati os were no ted in the fibrobl as ts fro m pati ents with morphea o r fa milial cutaneous collagenom a. It should be noted that type IIIII procollagen mRNA ratios w ere m easured in patients' fibroblas t cultures which we re incubated parallel to the contro l cell cultures under identical conditio ns. Thus, the altered collagen ge ne expressio n in fibroti c diseases m ay be selective in that one o f the geneti cally di stin ct types of colla gens is preferentially expressed .
In summ ary , enhanced procollagen productio n w as dem o nstrated in fibrobl as t cultures es tablished from several patients with fibr o ti c skin diseases. A cl ose correlation between the procoll agen produ cti on and type I procollage n mRNA levels w as noted , suggesting regul ati on on th e pretranslational level of procollagen gene expression . These observations furth er suggest that the ac-
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cumulatio n o f collagen in these conditions m ay res ult from enhanced synthesis o f this pro tein in vivo. It should be noted that the diseases examined in this study w ere representative only of som e of the distinct ca tegories of derm al fibrosis. It is clea r that m any o f the ca tegories wi thin the proposed classifi ca ti on o f the cutaneous diseases with dermal fibrosis (see T able I) are heterogeneous bo th clinically and biochemically . Furthermore, previo us biochemi cal studies on collage n biosynthesis in a large number o f fibrobl as t cultures es tablished from pati ents with keloids [8] o r progressive systemic sclerosis [11] have revealed considerable hetero geneity . Thus, the cell lines studied here m ay no t be exclusively representative of the pheno typi c expressio n within each di agnosti c ca tegory, and it is conceivable that in o ther cases with fibro ti c cutaneous diseases , additional facto rs, such as translation al and posttranslational control of pro tein synthesis or altered degradative path way [1 9,43] 
